The outcomes from a multi-centre study have revealed the effectiveness of the EndoZip system in achieving significant weight loss, with an average total body weight loss (TBWL) of 13.21% at 12 months. EndoZip is a fully automated endoscopic suturing system, offering a minimally invasive approach for obesity class I and II patients, which according to the device’s developers Nitinotes, ensures consistent, safe suturing with the press of a button, representing a significant advancement in the field.
The outcomes will soon be published in the paper, ‘Automatic Endoscopic Gastroplasty for the Treatment of Obesity: Results From a Prospective Multicenter Study’, in the journal, GIE: Gastrointestinal Endoscopy. Additionally, the study highlighted notable improvements in metabolic health indicators such as reductions in waist circumference, haemoglobin A1C (HbA1C) and alanine aminotransferase (ALT) levels, which are critical in managing obesity-related comorbidities. Quality of life improvements were also significant, as measured by the IWQOL questionnaire, underscoring the comprehensive benefits of the procedure beyond just weight reduction. The technical success of the procedure was achieved in all patients, demonstrating its ease of performance, safety, and feasibility, with a low incidence of reported adverse events.
The company believes the study positions EndoZip as a valuable alternative to existing minimally invasive obesity treatments, broadening access to patients who might not qualify or do not want to undergo bariatric surgery.
"The acceptance of our study for publication in GIE validates the potential of EndoZip technology. It aligns with our mission to enhance the accessibility and reduce the invasiveness of obesity treatments,” said Lloyd Diamond, CEO of Nitinotes. “We believe EndoZip could help more physicians incorporate this technology into their practices, providing an additional option for patients seeking alternatives to traditional medical and surgical interventions.”
This study contributes to ongoing advancements in obesity management and the broader adoption of less invasive procedures, furthering Nitinotes' vision of transforming obesity treatment through cutting-edge, minimally invasive technologies, the company stated in a press release.
Comments